Glioma Latest Advances

Find the Latest Research About Glioma

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 138593 publications

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

Journal: Expert review of anticancer therapy
Published: June 24, 2026

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Journal: Expert review of neurotherapeutics
Published: June 24, 2026

Decreased miR-1305 expression is associated with tumour invasiveness and poor prognosis in glioma patients.

Decreased miR-1305 expression is associated with tumour invasiveness and poor prognosis in glioma patients.

Journal: The International journal of neuroscience
Published: June 23, 2026

Recurrence Associated IGFBP2 Promotes Malignant Progression and Epithelial Mesenchymal Transition in Glioma Cells via the AKT mTOR Pathway.

Recurrence Associated IGFBP2 Promotes Malignant Progression and Epithelial Mesenchymal Transition in Glioma Cells via the AKT mTOR Pathway.

Journal: The International journal of neuroscience
Published: June 23, 2026

Retraction Note: UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma.

Retraction Note: UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma.

Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: June 23, 2026

RETRACTION: Long Non-Coding RNA HCG11 Modulates Glioma Progression Through Cooperating With miR-496/CPEB3 Axis.

RETRACTION: Long Non-Coding RNA HCG11 Modulates Glioma Progression Through Cooperating With miR-496/CPEB3 Axis.

Journal: Cell proliferation
Published: June 23, 2026

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

Correction: Molecular subtypes and the (in vitro) response of glioblastoma to temozolomide.

Journal: BJC reports
Published: June 23, 2026

Reply to "Correspondence: Androgen receptor mRNA in glioblastoma: a reliable marker of tumor burden or a statistical artefact?"

Reply to "Correspondence: Androgen receptor mRNA in glioblastoma: a reliable marker of tumor burden or a statistical artefact?"

Journal: Molecular biology reports
Published: June 23, 2026

Impact of weak MGMT promoter methylation on the prognosis of patients with newly diagnosed glioblastoma.

Impact of weak MGMT promoter methylation on the prognosis of patients with newly diagnosed glioblastoma.

Journal: Journal of neurosurgical sciences
Published: June 23, 2026

Single-nucleus multiomics unveils malignant cellular states, regulatory architectures and microenvironmental reorganization across the G-CIMP epigenomic transition in IDH-mutant glioma.

Single-nucleus multiomics unveils malignant cellular states, regulatory architectures and microenvironmental reorganization across the G-CIMP epigenomic transition in IDH-mutant glioma.

Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026

Glioblastoma-derived extracellular vesicles released after radiation promote cognitive impairment through NFκB-mediated microglial activation.

Glioblastoma-derived extracellular vesicles released after radiation promote cognitive impairment through NFκB-mediated microglial activation.

Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026

Intra-slide calibration technology improves immunohistochemical harmonization within and between anatomic pathology laboratories.

Intra-slide calibration technology improves immunohistochemical harmonization within and between anatomic pathology laboratories.

Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026
Showing 1-12 of 138,593

Last Updated: 06/30/2026